DENTSPLY SIRONA Inc. (XRAY) SVP granted RSU dividends and phantom stock

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. senior executive Robert Anthony Johnson, SVP and Chief Supply Chain Officer, reported routine equity compensation grants. On January 9, 2026, he acquired 641.625 shares of common stock at a price of $0, representing dividends on existing restricted stock units paid in the form of additional RSUs that vest on the same schedule as the underlying awards. After this, he beneficially owned 116,313.146 shares of common stock directly.

On the same date, he was credited with 40.22 phantom stock units under the Supplemental Executive Retirement Plan at a reference price of $12.22 per unit, bringing his total phantom stock balance to 3,113.1526 units. Each RSU and each phantom stock unit is economically equivalent to one share of common stock, with phantom stock payable in common stock upon his termination of employment.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Robert Anthony

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28222

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Supply Chain Office

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		641.625(1)	A	$0	116,313.146(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP	(3)	01/09/2026		A		40.22(4)		(3)	(3)	Common Stock	40.22	$12.22	3,113.1526	D

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

2. Includes 514 shares acquired between July 1st - December 31, 2025 under the Dentsply Sirona Employee Stock Purchase Plan.

3. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.

4. Comprised of phantom stock acquired as a result of accrued dividends.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Robert Anthony Johnson	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DENTSPLY SIRONA (XRAY) executive Robert Johnson report in this Form 4?

Robert Anthony Johnson, SVP and Chief Supply Chain Officer of DENTSPLY SIRONA Inc., reported acquisitions of common stock and phantom stock units as part of his equity compensation. These were not open-market purchases or sales but awards and dividend equivalents tied to his existing compensation plans.

How many DENTSPLY SIRONA common shares did Robert Johnson acquire?

On January 9, 2026, he acquired 641.625 shares of common stock at a price of $0, representing dividends on previously granted restricted stock units. Following this transaction, he directly beneficially owned 116,313.146 common shares.

What are the RSU dividend shares mentioned in the XRAY Form 4 filing?

The 641.625 shares represent dividends on restricted stock units awarded to Robert Johnson, paid in the form of additional RSUs. These dividend RSUs follow the same vesting schedule as the underlying RSUs, and each RSU converts into one share of DENTSPLY SIRONA common stock when it vests.

What phantom stock units did Robert Johnson receive from DENTSPLY SIRONA?

He received 40.22 phantom stock units under the Supplemental Executive Retirement Plan (SERP) at a reference price of $12.22 per unit. After this credit, he held 3,113.1526 phantom stock units, each economically equivalent to one share of common stock.

When do DENTSPLY SIRONA phantom stock units become payable to Robert Johnson?

According to the filing, each share of phantom stock is the economic equivalent of one share of common stock and becomes payable in common stock upon the reporting person’s termination of employment.

Were any of Robert Johnson’s DENTSPLY SIRONA shares sold in this Form 4?

No sales were reported. The Form 4 shows acquisitions of common stock through RSU dividend equivalents and additions of phantom stock units under a retirement plan, all reported as directly owned.